[1]     Marshall LM，Spiegelman D，Barbieri RL，et al.Variation in the incidence of uterine leiomyoma among premenopausal women by age and race[J]. Obstet Gynecol, 1997, 90：967-973.

[2]     Schwartz SM.Epidemiology of uterine leiomyomata[J]. Clin Obstet Gynecol, 2001, 44：316-326.

[3]     Zimmermann A，Bernuit D，Gerlinger C，et al.Prevalence，symptoms and management of uterine fibroids：an international internet-based survey of 21 746 women[J]. BMC Womens Health，2012，12：6-12.

[4]     Myers ER, Barber MD, Gustilo-Ash BT, et al．Management of uterine leiomyomata what do we really know[J].Obstet Gynecol, 2002,100(1):8-17.

[5]     曹泽毅，翁梨驹，郎景和，等.中华妇产科学（上、中、下册）[M].2版.北京：人民卫生出版社，2014：2082-2087.

[6]     Chrisman HB, Saker MBR, Yu RK, et al．The impact of uterine fibroid embolization on resumption of menses and ovarian function[J]．J Vasc Interv Radiol,2009,116:699-703．

[7]     Ahmad AQ,Adan L,Hassan N, et al．Uterine artery embolization treatment of uterine fibroids effect on ovarian function in younger women[J]. J Vasc Interv Radiol, 2012,13(10):1017-1020．

[8]     Yoo EH，Lee PI，Huh CY，et al.Predictors of leiomyoma recurrence after laparoscopic myomectomy[J].J Minim Invasive Gynecol，2013，14（6）：690-697.

（2015-10-30收稿）